Literature DB >> 33479542

Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.

Stefan Terlecki-Zaniewicz1,2, Theresa Humer1, Thomas Eder1, Johannes Schmoellerl1, Elizabeth Heyes1, Gabriele Manhart1, Natalie Kuchynka3, Katja Parapatics4, Fabio G Liberante1, André C Müller4, Eleni M Tomazou2, Florian Grebien5.   

Abstract

NUP98 fusion proteins cause leukemia via unknown molecular mechanisms. All NUP98 fusion proteins share an intrinsically disordered region (IDR) in the NUP98 N terminus, featuring repeats of phenylalanine-glycine (FG), and C-terminal fusion partners often function in gene control. We investigated whether mechanisms of oncogenic transformation by NUP98 fusion proteins are hardwired in their protein interactomes. Affinity purification coupled to mass spectrometry (MS) and confocal imaging of five NUP98 fusion proteins expressed in human leukemia cells revealed that shared interactors were enriched for proteins involved in biomolecular condensation and that they colocalized with NUP98 fusion proteins in nuclear puncta. We developed biotinylated isoxazole-mediated condensome MS (biCon-MS) to show that NUP98 fusion proteins alter the global composition of biomolecular condensates. An artificial FG-repeat-containing fusion protein phenocopied the nuclear localization patterns of NUP98 fusion proteins and their capability to drive oncogenic gene expression programs. Thus, we propose that IDR-containing fusion proteins combine biomolecular condensation with transcriptional control to induce cancer.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33479542      PMCID: PMC7116736          DOI: 10.1038/s41594-020-00550-w

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  65 in total

Review 1.  The emerging complexity of gene fusions in cancer.

Authors:  Fredrik Mertens; Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

Review 2.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

3.  Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes.

Authors:  Maya Capelson; Yun Liang; Roberta Schulte; William Mair; Ulrich Wagner; Martin W Hetzer
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

4.  The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex.

Authors:  A Radu; M S Moore; G Blobel
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

5.  The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.

Authors:  Karthik B Jeganathan; Liviu Malureanu; Jan M van Deursen
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

6.  NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.

Authors:  S Struski; S Lagarde; P Bories; C Puiseux; N Prade; W Cuccuini; M-P Pages; A Bidet; C Gervais; M Lafage-Pochitaloff; C Roche-Lestienne; C Barin; D Penther; N Nadal; I Radford-Weiss; M-A Collonge-Rame; B Gaillard; F Mugneret; C Lefebvre; E Bart-Delabesse; A Petit; G Leverger; C Broccardo; I Luquet; M Pasquet; E Delabesse
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

Review 7.  The impact of translocations and gene fusions on cancer causation.

Authors:  Felix Mitelman; Bertil Johansson; Fredrik Mertens
Journal:  Nat Rev Cancer       Date:  2007-03-15       Impact factor: 60.716

8.  The network organization of cancer-associated protein complexes in human tissues.

Authors:  Jing Zhao; Sang Hoon Lee; Mikael Huss; Petter Holme
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Differential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.

Authors:  S Reckel; R Hamelin; S Georgeon; F Armand; Q Jolliet; D Chiappe; M Moniatte; O Hantschel
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

10.  MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.

Authors:  Anna Skucha; Jessica Ebner; Johannes Schmöllerl; Mareike Roth; Thomas Eder; Adrián César-Razquin; Alexey Stukalov; Sarah Vittori; Matthias Muhar; Bin Lu; Martin Aichinger; Julian Jude; André C Müller; Balázs Győrffy; Christopher R Vakoc; Peter Valent; Keiryn L Bennett; Johannes Zuber; Giulio Superti-Furga; Florian Grebien
Journal:  Nat Commun       Date:  2018-05-18       Impact factor: 17.694

View more
  13 in total

Review 1.  Biomolecular Condensation: A New Phase in Cancer Research.

Authors:  Anupam K Chakravarty; Daniel J McGrail; Thomas M Lozanoski; Brandon S Dunn; David J H Shih; Kara M Cirillo; Sueda H Cetinkaya; Wenjin Jim Zheng; Gordon B Mills; S Stephen Yi; Daniel F Jarosz; Nidhi Sahni
Journal:  Cancer Discov       Date:  2022-09-02       Impact factor: 38.272

2.  Molecular interactions of FG nucleoporin repeats at high resolution.

Authors:  Alain Ibáñez de Opakua; James A Geraets; Benedikt Frieg; Christian Dienemann; Adriana Savastano; Marija Rankovic; Maria-Sol Cima-Omori; Gunnar F Schröder; Markus Zweckstetter
Journal:  Nat Chem       Date:  2022-09-22       Impact factor: 24.274

3.  Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.

Authors:  Bappaditya Chandra; Nicole L Michmerhuizen; Hazheen K Shirnekhi; Swarnendu Tripathi; Brittany J Pioso; David W Baggett; Diana M Mitrea; Ilaria Iacobucci; Michael R White; Jingjing Chen; Cheon-Gil Park; Huiyun Wu; Stanley Pounds; Anna Medyukhina; Khaled Khairy; Qingsong Gao; Chunxu Qu; Sherif Abdelhamed; Scott D Gorman; Simranjot Bawa; Carolyn Maslanka; Swati Kinger; Priyanka Dogra; Mylene C Ferrolino; Danika Di Giacomo; Cristina Mecucci; Jeffery M Klco; Charles G Mullighan; Richard W Kriwacki
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

Review 4.  Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies.

Authors:  Richoo B Davis; Mahdi Muhammad Moosa; Priya R Banerjee
Journal:  Trends Cell Biol       Date:  2022-04-25       Impact factor: 21.167

Review 5.  Phase separation in genome organization across evolution.

Authors:  Marina Feric; Tom Misteli
Journal:  Trends Cell Biol       Date:  2021-03-23       Impact factor: 21.167

6.  SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.

Authors:  Zivojin Jevtic; Vittoria Matafora; Francesca Casagrande; Fabio Santoro; Saverio Minucci; Massimilliano Garre'; Milad Rasouli; Olaf Heidenreich; Giovanna Musco; Jürg Schwaller; Angela Bachi
Journal:  J Exp Clin Cancer Res       Date:  2022-01-24

Review 7.  Biomolecular condensates in cancer biology.

Authors:  Hiroshi I Suzuki; Koh Onimaru
Journal:  Cancer Sci       Date:  2021-12-14       Impact factor: 6.716

8.  A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia.

Authors:  Chi-Keung Cheng; Hoi-Yun Chan; Yuk-Lin Yung; Thomas S K Wan; Alex W K Leung; Chi-Kong Li; Ke Tian; Natalie P H Chan; Joyce S Cheung; Margaret H L Ng
Journal:  Blood Adv       Date:  2022-01-25

9.  The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype.

Authors:  Marcela Vaz; Birthe Fahrenkrog
Journal:  Cells       Date:  2021-10-22       Impact factor: 6.600

Review 10.  14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation.

Authors:  Xianlong Huang; Zhiwen Zheng; Yixin Wu; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Biochem Biophys       Date:  2022-02-10       Impact factor: 2.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.